(1) A
"positive behaviour support plan" , for an adult with an intellectual or
cognitive disability, is a plan that describes the strategies to be used to—
(a) meet the adult’s needs; and
(b) support the adult’s development of
skills; and
(c) maximise opportunities through which the adult can improve
their quality of life; and
(d) reduce the intensity, frequency and duration
of the adult’s behaviour that causes harm to the adult or others.
(a) in
relation to previous behaviour of the adult that has caused harm to the adult
or others, a description of—
(i) the intensity, frequency and duration of
the behaviour; and
(ii) the consequences of the behaviour; and
(iii) the
early warning signs and triggers for the behaviour, if known;
(b) the
positive strategies that must be attempted before using a restrictive
practice, including the community access arrangements in place for the adult;
(c) for each restrictive practice proposed to be used in relation to the
adult—
(i) the circumstances in which the restrictive practice is to be
used; and
(ii) a demonstration of why use of the restrictive practice is the
least restrictive way of ensuring the safety of the adult or others; and
(iii) the procedure for using the restrictive practice, including observations
and monitoring, that must happen while the restrictive practice is being used;
and
(iv) any other measures that must happen while the restrictive practice
is being used that are necessary to ensure—
(A) the adult’s proper care
and treatment; and
(B) the adult is safeguarded from abuse, neglect and
exploitation; and
(v) a description of the anticipated positive and negative
effects on the adult of using the restrictive practice; and
(vi) the
intervals at which use of the restrictive practice will be reviewed by the
relevant service provider using the restrictive practice;
(d) for
seclusion—the maximum period for which seclusion may be used at any 1 time
and the maximum frequency of the seclusion;
(e) for chemical restraint—
(i)
the name of the medication to be used and any available information about the
medication, including, for example, information about possible side effects;
and
(ii) the dose, route and frequency of administration, including, for
medication to be administered as and when needed, the circumstances in which
the medication may be administered, as prescribed by the adult’s treating
doctor; and
(iii) if the adult’s medication has previously been reviewed by
the adult’s treating doctor—the date of the most recent medication review;
and
(iv) the name of the adult’s treating doctor;
(f) for mechanical or
physical restraint—the maximum period for which the restraint may be used at
any 1 time.
(3) For subsection (2) (c) (vi) , use of a restrictive practice
must be reviewed—
(a) for a restrictive practice not used under a
containment or seclusion approval—at least once during each 12-month period;
or
(b) for a restrictive practice used under a containment or seclusion
approval—when required by the chief executive, and at least once during the
period of the approval.
